|Bid||264.64 x 900|
|Ask||264.76 x 800|
|Day's Range||261.89 - 273.39|
|52 Week Range||231.23 - 386.80|
|Beta (3Y Monthly)||1.48|
|PE Ratio (TTM)||104.16|
|Earnings Date||Oct 16, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||386.90|
Prudent investors pay attention to money flows because that gives them an edge. Just like a doctor cannot see everything with the naked eye and may order an X-ray to figure out what is going on, segmented money flows are like X-rays of stocks. Please click here for a chart showing segmented money flows in 11 popular tech stocks.
Win for Phoebe Waller-Bridge blocks ‘Veep’ star Julia Louis-Dreyfus from setting record; Netflix acknowledged for ‘When They See Us’ about Central Park Five.
The stock’s year-to-date return slipped to a negative 1%—a stunning reversal given that it had been up as much as 44% in early May.
Netflix shares continue to slide amid worries that rising competition from Amazon, Apple, and Disney will erode its growth rates and market share.
Netflix (NFLX) has been the worst-performing FAANG stock, primarily due to slowing growth amid rising competition in the streaming space.
iQiyi (NASDAQ:IQ) may be up nearly 25% on the year, but at $18.53 it's a long way from the $27.70 it hit in February. And miles from last June when IQ stock topped $40. After slipping another 2.42% in trading on Friday, iQiyi stock continues to experience volatility.Source: Jarretera / Shutterstock.com Depending on your perspective, that could make it worth considering -- assuming it's going to rebound after this latest drop -- or you could decide that IQ is in for a rough ride and should be avoided for now.There's a case to be made for both positions.InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Bull Case for IQ StockSometimes referred to as the "Netflix (NASDAQ:NFLX) of China," iQiyi is a video streaming platform, which was spun off in 2018 from China's Baidu (NASDAQ:BIDU). * 7 Worst Stocks in the S&P 500 in 2019 Everyone is excited about video streaming at the moment. In the U.S., Netflix is preparing to defend its market dominance against a flood of new competition, including streaming video services from Disney (NYSE:DIS) and Apple (NASDAQ:AAPL). Billions of dollars are being spent on bidding for popular television shows to add to these services, while billions more are being invested in original content. Chinese consumers are also embracing video streaming, but the market there is in a much earlier stage. Where Netflix stock has taken hits because of slowing subscriber growth -- and an actual loss of subscribers in its increasingly saturated home market in the last quarter -- China is booming.The country has a massive population and plenty of room left for subscriber growth. The market for paid streaming video services in China is on track to triple in size by 2022 from 2018 levels, and by the end of 2018, three of the five largest subscription streaming video services globally were Chinese companies.Netflix still dominates (it closed 2018 with 24% of global streaming video subscribers), but iQiyi wasn't far behind at 15%. While iQiyi doesn't generate anywhere near the same revenue numbers as Netflix (in 2018, China's top three streamers combined for roughly $8 billion in revenue compared to $16 billion for Netflix), the company has been successfully converting users from free, ad-supported viewing to paid subscriptions.Adding to the bull case for IQ stock is the fact that strict regulations have kept American competition out of China. The closest Netflix has come to breaking into the market is to license original content to a Chinese streaming company -- iQiyi. Why There Is Hesitation About iQiyi StockWhile there is certainly a bull case for IQ stock, there are also many factors that are holding it back. Analysts currently have a median 12-month price target of $20.19, suggesting a lack of confidence that IQ is going to be trading anywhere near the levels it hit earlier this year -- let alone the $40 level it topped last summer.Despite its success in signing up subscribers, iQiyi's last quarterly earnings report showed worrying trends. InvestorPlace's Vince Martin points out that revenue slowed dramatically, advertising revenue declined double digits, and IQ's costs to produce and market original material continued to rise.The nature of the video streaming business means that if iQiyi reins in content spending, subscriber growth slows and it risks losing existing customers. At the same time, the trade war with the U.S. is hurting the economic climate in China. That makes consumers less likely to sign up for a subscription service, and makes existing customers resistant to price increases.Adding to the concerns, there have been rumblings that the Chinese government may consider opening up the country's video streaming market to foreign competition.While not insurmountable, these challenges are all weighing on IQ stock. There is no argument that iQiyi has seen considerable success in becoming a dominant player in the Chinese video streaming market, but there are an awful lot of potential obstacles ahead. Any one of these could hurt the company's prospects, making iQiyi stock a risky bet at this point if you're looking for a long-term growth stock.As of this writing, Brad Moon did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Worst Stocks in the S&P 500 in 2019 * 7 Reasons to Own Intuit Stock -- The Unsung Hero of Fintech * Apple and 4 Other Tech Stocks on the Move The post The Pros and Many Cons of iQiyi Stock appeared first on InvestorPlace.
Amazon scored multiple early victories at the 71st Emmy Awards Sunday night, with wins for comedies “The Marvelous Mrs. Maisel ” and “Fleabag.”
Netflix stock is threatening to break below its recent lows. It's now a key test of whether shares hold and bounce higher or fold and go lower.
Given Apple and Disney's aggressive pricing structure entering the streaming arena, Netflix's ability to increase prices is now threatened.
The market tried to work its way back into a bullish groove and end the week on a high note, but to no avail. By the time Friday's closing bell rang, the S&P 500 was 0.49% lower than Thursday's last trade. The true direction of the undertow remains in question.Source: Shutterstock Netflix (NASDAQ:NFLX) did more than its fair share of the damage, tumbling more than 5% after CEO Reed Hastings conceded looming competition from Walt Disney (NYSE:DIS) and others would be impressively tough. At the other end of the spectrum, though not by enough, was Fitbit (NYSE:FIT). The fitness tracker ticker jumped more than 11% on a rumor that it was considering selling itself to a so-far-unnamed suitor.Headed into the new trading week, it's the stock charts of MSCI (NYSE:MSCI), Abbott Laboratories (NYSE:ABT) and Macerich (NYSE:MAC) that are of the most interest. Here's why, and what's apt to be next.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Macerich (MAC)Macerich shares have been losing ground for a couple of years now, with seemingly no end in sight. Although up for the past few weeks, that move didn't necessarily snap the losing streak. * 7 Worst Stocks in the S&P 500 in 2019 Except, that gain may have set the stage for a recovery effort. After such a prolonged selloff, the stock's certainly ripe for a rebound. And, another missing link has finally materialized. Fortunately, the lines in the sand have become very clear. Click to Enlarge • The most important of those lines is the one that has steered MAC stock lower since the August-2018 peak, marked as a yellow dashed line on both stock charts.• The action over the course of the past month exhibits many of the clues of a reversal. Namely, volume swelled into the bottom from last month, and the turnaround has taken shape on even higher volume. It's a sign of a pivot from a net-selling to a net-buying environment.• Even if the falling resistance line is broken, notice the gray 100-day moving average line could still bring a quick end to that effort. It needs to be cleared as well. Abbott Laboratories (ABT)The past couple of months haven't been especially good ones for Abbott Laboratories shareholders. After an incredibly bullish summer following a great start to the new year, the stock has fallen back.That selloff is part of a well-established pattern, though, and that pattern has been amazingly well defined by straight support and resistance lines. ABT stock is somewhat in limbo right now, trapped between various floors and ceilings. Whether you want to buy it or short it depends on what happens next, and your intended timeframe. Click to Enlarge • There are two sets of support and resistance levels. The lesser ones are marked as yellow lines on both stock charts, while the bigger ones are plotted in light blue.• Though edging lower, the gray 100-day moving average line has thus far held up as a support level, much like it did back in May.• The white 200-day moving average line is also in play here, so if the short-term, yellow floor that's guided Abbott to higher lows since the end of last year doesn't hold up, ABT stock doesn't necessarily have to fall all the way back to the mid-$70's. MSCI (MSCI)Finally, although MSCI looked (and was) unstoppable through the first half of the year, the rally was stopped cold as the second half began. It didn't slip over the edge of the cliff though, so to speak, until last week -- and Friday in particular -- when a sizeable stumble dragged shares below a trio of key moving average lines. Those same moving averages, in fact, also dished out sell signals of their own. Click to Enlarge • The divergence of those three moving average lines that started to take shape in February has not only ended, the convergence is starting to become a divergence again … in the other direction.• Take a close look at the daily volume bars, and the red, bearish ones in particular. They've become decidedly taller than average since July, and continue to rise.• Zooming out to the weekly chart of MSCI stock makes clear just how overextended this off-the-radar financial services was. It also illustrates how the gray 100-day moving average line has been a make-or-break level in the past … the white 200-day moving average line as well, although less so.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about him at his website jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Worst Stocks in the S&P 500 in 2019 * 7 Reasons to Own Intuit Stock -- The Unsung Hero of Fintech * Apple and 4 Other Tech Stocks on the Move The post 3 Big Stock Charts for Monday: MSCI, Macerich and Abbott Laboratories appeared first on InvestorPlace.
HBO dominated Sunday night’s Emmy awards, scoring the most wins of any network or platform thanks to hits such as Game of Thrones and Chernobyl. Elliott argues that AT&T is bloated after making too many pricey acquisitions in the past decade.
Stocks rose Monday afternoon, but gains were modest as investors face rising oil prices, uncertain trade negotiations, and weakness in global growth.
Jim Cramer's tackling the IPO scene and whether or not investors should be worried about Netflix's lack of Emmy Awards wins. Should You Be Worried About Suboptimal IPO's? Cramer wrote about IPO's in his Real Money column Monday morning.
Big wins at the 71st Emmy Awards last night - with HBO in the lead taking home awards for its shows Game of Thrones and Cherynobyl; as well as, Amazon, conquering in comedy, proving the success of the streaming world. Yahoo Finance's Adam Shapiro discusses with the panel.
The streaming wars are heating up, and Netflix is looking to original content to keep subscribers loyal and attract new numbers.